37 related articles for article (PubMed ID: 33476742)
1. Partial recovery of peripheral blood monocyte subsets in head and neck squamous cell carcinoma patients upon radio(chemo)therapy is associated with decreased plasma CXCL11.
Idel C; Fleckner J; Plötze-Martin K; Werner L; Rades D; Theodoraki MN; Hofmann L; Huber D; Leichtle A; Hoffmann TK; Bruchhage KL; Pries R
BMC Cancer; 2024 Apr; 24(1):459. PubMed ID: 38609887
[TBL] [Abstract][Full Text] [Related]
2. Immune restoration in head and neck cancer patients after in vivo COX-2 inhibition.
Lang S; Tiwari S; Andratschke M; Loehr I; Lauffer L; Bergmann C; Mack B; Lebeau A; Moosmann A; Whiteside TL; Zeidler R
Cancer Immunol Immunother; 2007 Oct; 56(10):1645-52. PubMed ID: 17387473
[TBL] [Abstract][Full Text] [Related]
3. Depressed monocyte polarization and clustering of dendritic cells in patients with head and neck cancer: in vitro restoration of this immunosuppression by thymic hormones.
Tas MP; Simons PJ; Balm FJ; Drexhage HA
Cancer Immunol Immunother; 1993; 36(2):108-14. PubMed ID: 8425208
[TBL] [Abstract][Full Text] [Related]
4. Activated Platelets Convert CD14
Lee SJ; Yoon BR; Kim HY; Yoo SJ; Kang SW; Lee WW
Front Immunol; 2020; 11():611133. PubMed ID: 33488616
[TBL] [Abstract][Full Text] [Related]
5. Association between circulating immune cells and the risk of prostate cancer: a Mendelian randomization study.
Hao X; Ren C; Zhou H; Li M; Zhang H; Liu X
Front Endocrinol (Lausanne); 2024; 15():1358416. PubMed ID: 38405157
[TBL] [Abstract][Full Text] [Related]
6. Monocytes in Tumorigenesis and Tumor Immunotherapy.
Chen X; Li Y; Xia H; Chen YH
Cells; 2023 Jun; 12(13):. PubMed ID: 37443711
[TBL] [Abstract][Full Text] [Related]
7. Plasma‑derived CD16 exosomes and peripheral blood monocytes as correlating biomarkers in head and neck cancer.
Theodoraki MN; Hofmann L; Huber D; Brunner C; Hoffmann TK; Idel C; Fleckner J; Bruchhage KL; Pries R
Oncol Lett; 2023 May; 25(5):200. PubMed ID: 37113401
[TBL] [Abstract][Full Text] [Related]
8. Quantitative, Spatially Defined Expression of Leukocyte-associated Immunoglobulin-like Receptor in Non-small Cell Lung Cancer.
Aung TN; Gavrielatou N; Vathiotis IA; Fernandez AI; Shafi S; Yaghoobi V; Burela S; MacNeil T; Ahmed FS; Myint H; Flies DB; Langermann S; Rimm DL
Cancer Res Commun; 2023 Mar; 3(3):471-482. PubMed ID: 36960400
[TBL] [Abstract][Full Text] [Related]
9. Insight on common forms of cutaneous head and neck carcinoma (Review).
Iancu DC; Fulga A; Vesa D; Stan C; Zenovia A; Bujoreanu F; Piraianu AI; Sarbu MI; Tatu AL
Mol Clin Oncol; 2023 Apr; 18(4):28. PubMed ID: 36908978
[TBL] [Abstract][Full Text] [Related]
10. Macrophage and monocyte subsets as new therapeutic targets in cancer immunotherapy.
Fendl B; Berghoff AS; Preusser M; Maier B
ESMO Open; 2023 Feb; 8(1):100776. PubMed ID: 36731326
[TBL] [Abstract][Full Text] [Related]
11. Ewing Sarcoma and Osteosarcoma Have Distinct Immune Signatures and Intercellular Communication Networks.
Cillo AR; Mukherjee E; Bailey NG; Onkar S; Daley J; Salgado C; Li X; Liu D; Ranganathan S; Burgess M; Sembrat J; Weiss K; Watters R; Bruno TC; Vignali DAA; Bailey KM
Clin Cancer Res; 2022 Nov; 28(22):4968-4982. PubMed ID: 36074145
[TBL] [Abstract][Full Text] [Related]
12. Inflammatory landscape in Xeroderma pigmentosum patients with cutaneous melanoma.
Chikhaoui A; Jones M; Režen T; Ben Ahmed M; Naouali C; Komel R; Zghal M; Boubaker S; Abdelhak S; Yacoub-Youssef H
Sci Rep; 2022 Aug; 12(1):13854. PubMed ID: 35974070
[TBL] [Abstract][Full Text] [Related]
13. Increased Abundances of CD16
Idel C; Polasky C; Ribbat-Idel J; Loyal K; Perner S; Rades D; Bruchhage KL; Pries R
Biomedicines; 2022 Jun; 10(6):. PubMed ID: 35740384
[TBL] [Abstract][Full Text] [Related]
14. Smoking-, Alcohol-, and Age-Related Alterations of Blood Monocyte Subsets and Circulating CD4/CD8 T Cells in Head and Neck Cancer.
Idel C; Loyal K; Rades D; Hakim SG; Schumacher U; Bruchhage KL; Pries R
Biology (Basel); 2022 Apr; 11(5):. PubMed ID: 35625386
[TBL] [Abstract][Full Text] [Related]
15. The Role of miRNA in Regulating the Fate of Monocytes in Health and Cancer.
Alwani A; Andreasik A; Szatanek R; Siedlar M; Baj-Krzyworzeka M
Biomolecules; 2022 Jan; 12(1):. PubMed ID: 35053248
[TBL] [Abstract][Full Text] [Related]
16. Immunological features of circulating monocyte subsets in patients with squamous cell carcinoma of the head and neck.
Sakakura K; Takahashi H; Motegi SI; Yokobori-Kuwabara Y; Oyama T; Chikamatsu K
Clin Immunol; 2021 Apr; 225():108677. PubMed ID: 33476742
[TBL] [Abstract][Full Text] [Related]
17. Immunosuppressive activity of CD14+ HLA-DR- cells in squamous cell carcinoma of the head and neck.
Chikamatsu K; Sakakura K; Toyoda M; Takahashi K; Yamamoto T; Masuyama K
Cancer Sci; 2012 Jun; 103(6):976-83. PubMed ID: 22360618
[TBL] [Abstract][Full Text] [Related]
18. An unbalanced PD-L1/CD86 ratio in CD14(++)CD16(+) monocytes is correlated with HCV viremia during chronic HCV infection.
Zheng J; Liang H; Xu C; Xu Q; Zhang T; Shen T; Lu F
Cell Mol Immunol; 2014 May; 11(3):294-304. PubMed ID: 24531620
[TBL] [Abstract][Full Text] [Related]
19. A Novel, Five-Marker Alternative to CD16-CD14 Gating to Identify the Three Human Monocyte Subsets.
Ong SM; Teng K; Newell E; Chen H; Chen J; Loy T; Yeo TW; Fink K; Wong SC
Front Immunol; 2019; 10():1761. PubMed ID: 31402918
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
